Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered question first ministerially corrected answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

224735

	registered interest
	date	03/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clinical Commissioning Groups: Cumbria
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what funding (a) in total and (b) per capita has been allocated for Cumbria Clinical Commissioning Group for each year from 2013-14 to 2019-20.
	tabling member constituency	Copeland
	tabling member printed	Mr Jamie Reed
	uin	226114
	answer	answer is ministerial correction date of answer 06/03/2015 answer text <p>Clinical commissioning group (CCG) funding has not been decided beyond 2015/16. Notified revenue allocations and per capita allocations for Cumbria CCG are:</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Allocation £000</p></td><td><p>Per capita £</p></td></tr><tr><td><p>2013/14</p></td><td><p><del class="ministerial">692,122</del></p><p><ins class="ministerial">663,133</ins></p></td><td><p><del class="ministerial">1,330</del></p><p><ins class="ministerial">1,274</ins></p></td></tr><tr><td><p>2014/15</p></td><td><p>677,324</p></td><td><p>1,299</p></td></tr><tr><td><p>2015/16</p></td><td><p>685,654</p></td><td><p>1,313</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>These figures exclude running cost and Better Care Fund allocations.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 06/03/2015 14:39:07 question first ministerially corrected 19/03/2015 18:02:16 answering member 4020 label Biography information for George Freeman previous answer version 48371 answering member constituency Mid Norfolk answering member printed George Freeman answering member 4020 label Biography information for George Freeman
	tabling member	1503 label Biography information for Mr Jamie Reed

164370

	registered interest
	date	24/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Patients: Safety
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what plans he has to increase the use of patient experience surveys in the NHS to inform patient safety initiatives; and if he will make a statement.
	tabling member constituency	Copeland
	tabling member printed	Mr Jamie Reed
	uin	215718
	answer	answer is ministerial correction date of answer 27/11/2014 answer text <p>Patient experience surveys are a valuable source of evidence and the results are used in a range of ways, including the assessment of National Health Service performance as well as in regulatory activities such as registration, monitoring ongoing compliance and reviews. The Care Quality Commission has developed a new Intelligent Monitoring tool to give inspectors a clear picture of the areas of care that need to be followed up within an NHS acute trust or a specialist NHS trust. The system is built on a set of indicators that look at a range of information including patient experience, staff experience and performance.</p><p> </p><p> </p><p> </p><p>In addition to the patient experience surveys hospital boards and other providers and commissioners of services can also consider the results of the Friends and Family Test (FFT) to consider the implications for quality and safety. While not a traditional survey, the FFT provides near real-time feedback to identify both good and poor quality patient experience. A NHS England review of the FFT found that it is performing well as a service improvement tool, with 85% of trusts reporting that it is being used to improve patient experience, and 78% saying that FFT has increased the emphasis placed on patient experience in their trusts.</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 27/11/2014 17:09:16 answering member 4020 label Biography information for George Freeman
	tabling member	1503 label Biography information for Mr Jamie Reed

164375

	registered interest
	date	24/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, which patient groups and patient representative organisations his Department consulted before publication of Personalised Health and Care 2020: a framework for action.
	tabling member constituency	Copeland
	tabling member printed	Mr Jamie Reed
	uin	215651
	answer	answer is ministerial correction date of answer 27/11/2014 answer text <p>Input from patient and representative organisations was sought through the NHS England Citizen Engagement and INVOLVE networks. No formal consultation exercise was conducted.</p><p> </p><p> </p><p> </p><p>Members from these groups participated in a facilitated workshop, offering insight and the opportunity for patient and public input to a series of developing outcomes which now form the key proposals within the Framework.</p><p> </p><p> </p><p> </p><p>The Framework was socialised with The Richmond Group of Charities as part of a subject/sector specific ‘critical review panel’, the feedback from which helped shape onward drafting.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 27/11/2014 17:20:26 answering member 4020 label Biography information for George Freeman
	tabling member	1503 label Biography information for Mr Jamie Reed

169859

	registered interest
	date	11/12/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pharmaceutical Price Regulation Scheme
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what estimate his Department has made of the rebate from the PPRS scheme (a) in cash terms and (b) as a proportion of overall medicines spend in 2015-16 and 2016-17; and what earlier estimate his Department has made for that period.
	tabling member constituency	Copeland
	tabling member printed	Mr Jamie Reed
	uin	218420
	answer	answer is ministerial correction date of answer 16/12/2014 answer text <p>The Pharmaceutical Price Regulation Scheme (PPRS) payment estimate for the United Kingdom in 2015-16 is £995 million. The increase in PPRS payment estimates has been taken into account as part of the NHS Mandate allocation for 2015-16. The latest estimate of overall health service medicines spend (branded and generic) for England in 2013-14 is £13,339 million. This is the latest year for which data is available. As this is for a different period and is England only, it would be misleading to express the anticipated PPRS Payments for 2015-16 as a proportion of that spend.</p><p> </p><p> </p><p> </p><p>We do not intend to publish an estimate of cash payments for 2016-17, as it is not possible to make a reliable estimate looking this far ahead. The payment percentages for 2015 and 2016 are currently estimated to be 10.36% and 15.0% of eligible branded spend respectively, however 2016 will be adjusted on the basis of final outturn in 2014, 2015, and is therefore indicative.</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 16/12/2014 17:27:50 answering member 4020 label Biography information for George Freeman
	tabling member	1503 label Biography information for Mr Jamie Reed

223015

	registered interest
	date	23/02/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Nurses
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the NICE guidelines on safe staffing for nursing in A&E departments, published on 16 January 2015, what assessment (a) the National Institute for Health and Care Excellence, (b) Health Education England and (c) his Department has made of the (i) performance of A&E departments in meeting these ratios and (ii) number of full-time equivalent nurses required to meet the ratios across the NHS.
	tabling member constituency	Copeland
	tabling member printed	Mr Jamie Reed
	uin	224875
	answer	answer is ministerial correction date of answer 26/02/2015 answer text <p>The National Institute for Health and Care Excellence (NICE) has recently consulted stakeholders on its draft guidance on safe nurse staffing in accident and emergency departments and has not yet published its final guidance. The Department has made no assessment of current performance against the ratios set out in NICE’s draft guidance.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 26/02/2015 16:56:04 answering member 4020 label Biography information for George Freeman
	tabling member	1503 label Biography information for Mr Jamie Reed

92007

	registered interest
	date	26/09/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps (a) his Department and (b) the National Institute for Health and Care Excellence is taking to ensure that patients have access to drugs and treatments for ultra-rare diseases.
	tabling member constituency	Copeland
	tabling member printed	Mr Jamie Reed
	uin	209351
	answer	answer is ministerial correction date of answer 17/10/2014 answer text <p>The UK Strategy for Rare Diseases, published in November 2013, aims to ensure that patients with rare diseases have access to high quality care, including diagnostics, treatments, support and effective drug treatments.</p><p> </p><p> </p><p> </p><p>NHS England is responsible for directly commissioning specialised services accessed by comparatively small numbers of patients and has developed service specifications on a national basis, to ensure that patients can access the same high quality services and treatments regardless of where they live in England.</p><p> </p><p> </p><p> </p><p>From 1 April 2013 the National Institute for Health and Care Excellence (NICE) took responsibility for the evaluation of selected high cost, low volume drugs under its Highly Specialised Technologies Programme. NHS commissioners are legally obliged to provide funding for drugs that have been recommended in NICE technology appraisals or highly specialised technologies evaluations.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 17/10/2014 09:09:58 answering member 4020 label Biography information for George Freeman
	tabling member	1503 label Biography information for Mr Jamie Reed